EUVIMEDEUVIMED entdecken
Kommentar

Reprogramming tumor cells to fight cancer

Haibo Zhou, Li Wu

Science · 2024

DOI: 10.1126/science.ads6228 ↗

Kurz gefasst

Kommentar in der Zeitschrift Science, 2024. Verfasst von Haibo Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Dendritic Cells, Cellular Reprogramming, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells reprogrammed into dendritic cells in vivo promote antitumor immunity

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsCellular ReprogrammingNeoplasmsHumansAnimalsMice

Autor:innen und Institutionen

  • Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Institute for Immunology, School of Basic Medical Sciences, Tsinghua University, Beijing, China.
  • Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China.
  • Beijing Key Laboratory for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China.

Zitieren

APA

Zhou, H., & Wu, L. (2024). Reprogramming tumor cells to fight cancer. Science. https://doi.org/10.1126/science.ads6228

Vancouver

Zhou H, Wu L. Reprogramming tumor cells to fight cancer. Science. 2024. doi:10.1126/science.ads6228

BibTeX
@article{Zhou2024,
  author = {Zhou, Haibo and Wu, Li},
  title = {Reprogramming tumor cells to fight cancer},
  journal = {Science},
  year = {2024},
  doi = {10.1126/science.ads6228}
}
Kostenlos starten →